Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Categories
Adverse Events
Antibiotics
Antibody–Drug Conjugates
Anticoagulants
Biosimilars
Bispecific Antibodies
Cancer Types
CAR T-Cell Therapy
Case Reports
CDK4/6 Inhibitors
Checkpoint Inhibitors
Chemotherapy
Clinical Trials
Conference Highlights
Cost of Care
COVID-19
Disparities in Oncology Care
Dose Escalation/Reduction
Drug Resistance
Drug–Drug Interaction
Editorial
FDA Updates
From the Literature
HOPA Abstracts
HOPA Corner
Immunotherapy
Infections
Infusion Issues
JAK Inhibitors
Letters to the Editor
Methotrexate
Monoclonal Antibodies
Obesity
Oncology Pharmacy Programs/Protocols
Oral Therapy
Original Research
PARP Inhibitors
PD-1 Inhibitors
Perspective
Practical Issues in Pharmacy Management
Radiation Therapy
Review Article
Screening
Supportive Care
Symptom Management Overview
Targeted Therapies
Technology
Thromboembolism
Transplant
Tyrosine Kinase Inhibitor
Vaccinations
VEGF Inhibitors
Venetoclax